| abstract |
The present invention relatates to novel CD300LG polypeptides, more specifically soluble forms thereof and provides use thereof and methods for preventing and/or treating diseases and/or disorders such as inflammatory diseases, including various inflammatory autoimmune disorders, allergic hypersensitivity, allograft rejection and/or syndromes associated with increased CD300LG-FL polypeptide function on dendritic cells. |